Cost-effectiveness analysis of ropeginterferon alfa-2b for the management of patients with polycythemia vera in Japan.

Yamaguchi H, Sugimoto Y, Gotoh A, Ota S, Igari H, Murata T, Hanada K, Komatsu N, Kirito K

DOI: 10.1007/s12185-025-04136-4
Published: 2026 Apr
Container: International journal of hematology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s12185-025-04136-4,
  title = {Cost-effectiveness analysis of ropeginterferon alfa-2b for the management of patients with polycythemia vera in Japan.},
  author = {Yamaguchi H and Sugimoto Y and Gotoh A and Ota S and Igari H and Murata T and Hanada K and Komatsu N and Kirito K},
  year = {2026},
  journal = {International journal of hematology},
  doi = {10.1007/s12185-025-04136-4},
  url = {https://doi.org/10.1007/s12185-025-04136-4}
}

RIS

TY  - JOUR
TI  - Cost-effectiveness analysis of ropeginterferon alfa-2b for the management of patients with polycythemia vera in Japan.
AU  - Yamaguchi H
AU  - Sugimoto Y
AU  - Gotoh A
AU  - Ota S
AU  - Igari H
AU  - Murata T
AU  - Hanada K
AU  - Komatsu N
AU  - Kirito K
PY  - 2026
JO  - International journal of hematology
DO  - 10.1007/s12185-025-04136-4
UR  - https://doi.org/10.1007/s12185-025-04136-4
ER  -

APA

H, Y., Y, S., A, G., S, O., H, I., T, M., K, H., N, K., & K, K. (2026). Cost-effectiveness analysis of ropeginterferon alfa-2b for the management of patients with polycythemia vera in Japan.. International journal of hematology. https://doi.org/10.1007/s12185-025-04136-4

Source records

pubmed · retrieved 2026-09-26T14:26:31.739Z